ORBIMED ADVISORS LLC 13D/13G Filings for Kezar Life Sciences, Inc. (KZR)

ORBIMED ADVISORS LLC 13D and 13G filings for Kezar Life Sciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
6:47 pm
Sale		 2023-12-31 13G Kezar Life Sciences, Inc.
KZR		 ORBIMED ADVISORS LLC 192,700
2.700%		 -156,812decrease
(-44.87%)		 Filing
2023-02-14
4:32 pm
Purchase		 2022-12-31 13G Kezar Life Sciences, Inc.
KZR		 ORBIMED ADVISORS LLC 349,512
5.100%		 349,512increase
(New Position)		 Filing